G5 - Preventing Maternal Morbidity and Mortality Via Expanded Scope of Nursing Practice As First Responder in Hypertensive Crisis of Preeclampsia

1.00 Pharmacology Contact Hours


Title: G5 - Preventing Maternal Morbidity and Mortality Via Expanded Scope of Nursing Practice As First Responder in Hypertensive Crisis of Preeclampsia

Disciplines: Advanced Practice (AP), Childbearing (CB)

Learning Objectives:
  1. Describe the purpose and evidence-based rationale that promoted a paradigm change in the management of hypertensive women with preeclampsia-eclampsia
  2. Based on a patient’s pathophysiologic and cardiovascular state, determine the category/type of antihypertensive agent that is most likely to result in a positive response
  3. Develop an algorithm for treatment of patients diagnosed with preeclampsia-eclampsia in hypertensive crisis to include hydralazine (Apresoline), labetalol (Normodyne, Trandate) and nicardipine (Cardene
Submission Description:
Hypertensive crisis during an episode of preeclampsia, eclampsia or any of it’s variants present a life threatening and/or life altering emergency. Nurses are frequently first to identify blood pressure aberrations and to seek the right care for their patients. Recent reports of cerebral vascular accidents in women with preeclampsia who have relatively “normal” or slightly elevated systolic and diastolic pressures are changing long held beliefs on when antihypertensive agents should be administered. Using case studies, this presentation presents recommended order sets and clinical guidelines that all OB providers may use when treating hypertensive crisis from preeclampsia. Algorithms that assist in selection of a specific first-line agent, options for second-line agents, and new recommendations for a rescue antihypertensive medications are presented.
Tuesday, June 18, 2013: 3:15 PM-4:15 PM
Tennessee C (Gaylord Opryland)
Moderator:
Susan M. LeBlanc, RNC, BSN
Presenting Author:
Carol Jeanne Harvey, MS, BSN, RNC-OB, C-EFM